Picture of Metlife logo

MET Metlife News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsConservativeLarge CapSuper Stock

Life insurer MetLife's Q3 revenue misses estimates

Overview

MetLife Q3 2025 revenue missed analyst expectations

Adjusted EPS for Q3 2025 beats analyst expectations

Company returned $875 mln to shareholders via repurchases and dividends

Outlook

Company did not provide specific guidance for future quarters in its press release

Result Drivers

VARIABLE INVESTMENT INCOME - Higher private equity returns significantly boosted variable investment income, contributing to a 15% increase in adjusted earnings

PENSION RISK TRANSFERS - Secured $12 bln in pension risk transfer mandates in Q4, enhancing future revenue potential

ASIA SALES GROWTH - Asia sales grew 34% on a constant currency basis, driven by new retirement-oriented products in Japan and other markets

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 RevenueMiss$17.36 bln$18.81 bln (6 Analysts)
Q3 Adjusted EPSBeat$2.37$2.32 (15 Analysts)
Q3 EPS$1.22
Q3 Adjusted Net Income$1.58 bln
Q3 Net Income$818 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell" The average consensus recommendation for the life & health insurance peer group is "buy" Wall Street's median 12-month price target for MetLife Inc is $95.50, about 16.8% above its November 4 closing price of $79.46 The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago Press Release: ID:nBw94T4ZLa For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Metlife

See all news